Association of MEGSIN 2093C-2180T haplotype at the 3′ untranslated region with disease severity and progression of IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 21, Issue 6, 2006, Pages 1570-1574

  Xia, Yunfeng ^a   Li, Youji ^a   Du, Yong ^b   Yang, Niansheng ^a   Li, Caixia ^a   Leung, Joseph C K ^c   Lam, Man F ^c   Huang, Weijun ^a   Chen, Suqin ^a   Maxwell, Patrick H ^d   Lai, Kar N ^c   Wang, Yiming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Chinese; Genetic variations; Genotype phenotype relationship; IgAN; MEGSIN

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYTOSINE; MEGSIN; SERINE PROTEINASE INHIBITOR; TYROSINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MESANGIUM; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; UPREGULATION;

3' UNTRANSLATED REGIONS; ADULT; BASE SEQUENCE; CHINA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; PROTEINURIA; SERPINS; SEVERITY OF ILLNESS INDEX;

EID: 33744790329     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk096     Document Type: Article

References (22)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727
2. Maisonneuve P, Agodoa L, Gellert R et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165
3. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-347
4. Miyata T, Nangaku M, Suzuki D et al. A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J Clin Invest 1998; 102: 828-836
5. Suzuki D, Miyata T, Nangaku M et al. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. J Am Soc Nephrol 1999; 10: 2606-2613
6. Miyata T, Inagi R, Nangaku M et al. Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J Clin Invest 2002; 109: 585-593
7. Li YJ, Du Y, Li CX et al. Family-based association study showing that immunoglobulin A Nephropathy is associated with the polymorphisms 2093C and 2180T in the 3′ untranslated region of the Megsin gene. J Am Soc Nephrol 2004; 15: 1739-1743
8. Lee SM, Rao VM, Franklin WA et al. IgA Nephropathy: Morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314-322
9. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989
10. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
11. Feehally J. Predicting prognosis in IgA nephropathy. Am J Kidney Dis 2001; 38: 881-883
12. Kruithof EKO, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 1995; 86: 4007-4024
13. Bachmann F. The enigma PAI-2: Gene expression, evolutionary and functional aspects. Thromb Haemostasis 1995; 74: 172-179
14. Bird PI. Serpins and regulation of cell death. Results Probl Cell Differ 1998; 24: 63-89
15. O'Relly MS, Pirie-Shepherd S, Lane WS, Folkman J. Antiantiogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999; 285: 1926-1928
16. Inagi R, Miyata T, Imasawa T et al. Mesangial cell-predominant gene, megsin. Nephrol Dial Transplant 2002; 17 [Suppl 9]: 32-33
17. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196
18. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
19. Donadio JV, Bergstralh EJ, Grande JP et al. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002; 17: 1197-1203
20. Kobayashi Y, Kokubo T, Horii A et al. Prognostic prediction of long-term clinical courses in individual IgA nephropathy patients. Nephrology 1997; 3: 35-40
21. Daniel L, Sainna Y, Giorgi R et al. Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2000; 35: 13-20
22. Rauta V, Finne P, Fagerudd J et al. Factors associated with progression of IgA nephropathy are related to renal function. A model for estimating risk of progression in mild disease. Clin Nephrol 2002; 58: 85-94